Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 1, 2015, Pages 92-100

  Chiu, Chun Wei ^a   Li, Ming Chi ^a   Ko, Wen Chien ^a,b   Li, Chia Wen ^a   Chen, Po Lin ^a   Chang, Chia Ming ^a   Lee, Nan Yao ^a   Lee, Ching Chi ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bacteremia; Emergency department; Gram negative nonfermenters

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; PENICILLIN G; QUINOLONE DERIVATIVE; UREIDOPENICILLIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; COMMUNITY ACQUIRED INFECTION; DEMOGRAPHY; EMERGENCY WARD; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEALTH CARE FACILITY; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROORGANISM; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT REFERRAL; RESIDENT; RISK FACTOR; SURVIVAL RATE; ADOLESCENT; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY HEALTH SERVICE; GRAM NEGATIVE AEROBIC RODS AND COCCI; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GRAM-NEGATIVE AEROBIC BACTERIA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921370900     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.08.004     Document Type: Article

References (32)

1. Leibovici L., Greenshtain S., Cohen O., Mor F., Wysenbeek A.J. Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med 1991, 151:1801-1806.
2. Bates D.W., Pruess K.E., Lee T.H. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med 1995, 155:593-598.
3. Strehlow M.C., Emond S.D., Shapiro N.I., Pelletier A.J., Camargo C.A. National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med 2006, 48:326-331. 31:e1-3.
4. Leibovici L., Shraga I., Drucker M., Konigsberger H., Samra Z., Pitlik S.D. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998, 244:379-386.
5. Salomão R., Castelo Filho A., Pignatari A.C., Wey S.B. Nosocomial and community acquired bacteremia: variables associated with outcomes. Rev Paul Med 1993, 111:456-461.
6. McGowan J.E. Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am J Med 2006, 119(6 Suppl. 1):S29-S36.
7. Steinberg J.P., Del Rio C. Other gram-negative bacilli. Mandell's principles and practice of infectious diseases 2000, 2459-2474. Elsevier, Philadelphia. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
8. Quinn J.P. Clinical problems posed by multiresistant nonfermenting Gram-negative pathogens. Clin Infect Dis 1998, 27(Suppl. 1):S117-S124.
9. Vidal F., Mensa J., Almela M., Olona M., Martínez J.A., Marco F., et al. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. QJM 2003, 96:227-234.
10. Yu W.L., Wang D.Y., Lin C.W., Tsou M.F. Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates. Scand J Infect Dis 1999, 31:293-298.
11. Elting L.S., Bodey G.P. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990, 69:296-306.
12. Wisplinghoff H., Edmond M.B., Pfaller M.A., Jones R.N., Wenzel R.P., Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000, 31:690-697.
13. Siau H., Yuen K.Y., Ho P.L., Wong S.S., Woo P.C. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infect Dis 1999, 28:26-30.
14. Rahav G., Simhon A., Mattan Y., Moses A.E., Sacks T. Infections with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2). Medicine (Baltimore) 1995, 74:83-88.
15. Chang T.Y., Lee C.H., Liu J.W. Clinical characteristics and risk factors for fatality in patients with bloodstream infections caused by glucose non-fermenting Gram-negative bacilli. J Microbiol Immunol Infect 2010, 43:233-239.
16. Lodise T.P., Patel N., Kwa A., Graves J., Furuno J.P., Graffunder E., et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrobial Agents Chemother 2007, 51:3510-3515.
17. Bodey G.P., Jadeja L., Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 1985, 145:1621-1629.
18. Kang C.I., Kim S.H., Kim H.B., Park S.W., Choe Y.J., Oh M.D., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003, 37:745-751.
19. Lee N.Y., Chang T.C., Wu C.J., Chang C.M., Lee H.C., Chen P.L., et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia. J Infect 2010, 61:219-227.
20. Cisneros J.M., Reyes M.J., Pachon J., Becerril B., Caballero F.J., Garcia-Garmendia J.L., et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996, 22:1026-1032.
21. Schechner V., Nobre V., Kaye K.S., Leshno M., Giladi M., Rohner P., et al. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?. Clin Infect Dis 2009, 48:580-586.
22. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia. Clin Microbiol Infect 2005, 11:415-418.
23. Lee C.C., Lee C.H., Hong M.Y. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED. Am J Emerg Med 2011, 30:852-860.
24. Performance standards for antimicrobial disk susceptibility tests, 16th informational supplement CLSI document M100-S16 2006, Clinical and Laboratory Standards Institute (CLSI), CLSI, Wayne, PA.
25. Cheong H.S., Kang C.I., Wi Y.M., Kim E.S., Lee J.S., Ko K.S., et al. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med 2008, 121:709-714.
26. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004, 140:26-32.
27. Schellevis F.G., van der Velden J., van de Lisdonk E., van Eijk J.T., van Weel C. Comorbidity of chronic diseases in general practice. J Clin Epidemiol 1993, 46:469-473.
28. Lee C.C., Lin W.J., Shih H.I., Wu C.J., Chen P.L., Lee H.C., et al. Clinical significance of potential contaminants in blood cultures among patients in a medical center. J Microbiol Immunol Infect 2007, 40:438-444.
29. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140.
30. Chaowagul W., White N.J., Dance D.A., Wattanagoon Y., Naigowit P., Davis T.M., et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989, 159:890-899.
31. Ko W.C., Cheung B.M., Tang H.J., Shih H.I., Lau Y.J., Wang L.R., et al. Melioidosis outbreak after typhoon, southern Taiwan. Emerg Infect Dis 2007, 13:896-898.
32. Neu H.C. The role of Pseudomonas aeruginosa in infections. J Antimicrob Chemother 1983, 11(Suppl. B):1-13.